The Local Europe ABVästmannagatan 43113 25 StockholmSweden
The new three-in-one self-test will be sold in French pharmacies starting on Wednesday
The 'All in Triplex' test (you can see it here) will test for influenza (la grippe)
a respiratory illness that primarily affects children under 2
The test was developed by the French medical group AAZ
and it will be accessible for both adults and children
as the device is currently used in French emergency services at both the pediatric and adult levels
AAZ told Le Parisien that pharmacies will be able to dictate their own pricing
but they expect it will be sold for about €10 per single unit box
READ MORE: How France's 2024 flu and Covid vaccination campaigns work
The 'All in Triplex' is a nasal test - similar to the home-test kits for Covid though it is inserted less deeply than the typical nasopharyngeal Covid-19 self-test
it works by taking a nasal swab and then immersing the swab stick into the container of liquid provided and waiting for it to develop
The results strip has a positive or negative marker for each of the three viruses; Covid
The triple test will not be reimbursed by French public health insurance
Home tests kits (antigen) for Covid are no longer reimbursed either - except for children under 12 or healthcare workers - but it is still possible to get a reimbursement for a Covid-19 test which is done in the pharmacy or at a medical lab
These are usually reimbursed at 70 percent by French social security
and the remaining 30 percent is either paid for out of pocket or by the patient's complementary health plan (mutuelle)
There are some groups who have their Covid-19 tests fully reimbursed - these include;
You can also get an influenza test at a pharmacy without a prescription
Please log in here to leave a comment
Please enable JS and disable any ad blocker
A global alert about fake versions of Ozempic - which has become popular as a way of losing weight - has been issued by the World Health Organization (WHO)
The drug is sometimes known as a "skinny jab" despite its main purpose being a treatment for type 2 diabetes
The WHO said the fake medicines could pose a danger to health
The organisation advised people to source the drug only through reputable sources
rather than obscure sites online or through social media
The active ingredient in Ozempic - semaglutide - helps people with type 2 diabetes control the amount of sugar in their blood
the weekly injection also signals to the brain that we're full
So the drug helps people lose weight by reducing the urge to eat
People without diabetes have been getting hold of the drug as a weight-loss medication
It has led to shortages for people with type 2 diabetes and created a market for counterfeit drugs
The WHO said it had been tracking rising reports of dodgy Ozempic all around the world since 2022
Fake batches have been seized by the authorities in the United Kingdom
regulatory authorities and the public be aware of these falsified batches of medicines," said Dr Yukiko Nakatani
WHO assistant director general for essential medicines and health products
The WHO warned some fake injections may not contain semaglutide at all or others may contain other medications
"These falsified products could have harmful effects to people's health," the WHO said
The UK's drugs regulator seized a batch of fake Ozempic in October last year
They had come into the country from legitimate suppliers in Austria and Germany
said: "Buying semaglutide from illegally trading online suppliers significantly increases the risk of getting a product which is either falsified or not licensed for use in the UK."
She said injecting such products "may put your health at risk"
A higher strength version of Ozempic has been developed specifically for weight-loss and is marketed as Wegovy
This is being offered at specialist weight-loss clinics on the National Health Service in the UK
Billionaire Elon Musk is among those who have attributed their weight loss to the use of GLP-1 agonist diabetes drugs - but that's a concern for people who rely on the medications to stay well
Photographer Mohammed Sulaiman Nasser al Shaaili
has been adjudged Best Young Photographer and won a golden medal in an international competition organised by the International Federation of Photographic Art (FIAP)
The Salon Photo de Riedisheim international competition was launched in France online in April 2021 and the results declared later in the month.
I like photographing people’s faces and showcasing Oman’s natural beauty and diversity to the world through my work
I entered five photos in the competition for which there were a total of 5,125 submissions representing 45 countries.”
Shaaili has to date participated in international competitions in 13 countries and been feted at some of these
“I believe that a photographer must send a message through his photos
I strive to promote tourism in Oman by participating in international competitions.”
He takes the challenges he faces while shooting in his stride
“Reaching some locations to do photography
needs trekking for long over difficult terrain
Photography demands determination and patience,” he said.
“I thank the New View Photography Club for supporting me to take part in the contest in France.”
Currently pursuing an engineering programme in University of Technology and Applied Sciences in Ibri, Shaaili is eager to continue photographing Oman’s natural beauty
“This is my contribution to boost tourism in my beloved country.”
Shaaili hopes to hold a solo exhibition of his work soon
Muscat Daily is now the largest selling broadsheet newspaper in the Sultanate of Oman with 33,500 daily copies and 28,000 subscribers.
Muscat Daily provides unrivalled national news coverage from Oman
© 2021 Apex Press and Publishing. All Rights Reserved. Powered by Mesdac
New Zealand is at the bottom of the pile when it comes to the supply of weight loss drugs
because of seemingly endless international demand for them
The impact of weight loss drugs around the world is so huge that big food companies are jumping in on the bonanza
targeting people on the medication with special food lines
made famous by celebrities including Oprah Winfrey
are forecast to be worth $165 billion by the 2030s
They're so popular the pharmaceutical giants can't keep up with the demand from millions of people around the world
"New Zealand tends to be at the bottom of the list for pharmaceutical companies when it comes to supplying them," says Niki Bezzant
Even access to the Pharmac-funded drug Saxenda for people with type 2 diabetes is limited because of the squeeze on supply
And while drugs similar to Ozempic are available here they're not as effective in reducing weight and they cost $500 a month
That's out of reach for most New Zealanders when they're expected to stay on them for the rest of their lives
"If you start taking this for obesity then you're going to have to keep taking it to have the effect
You can't just go on it and then go off it," says Bezzant
"It's the same as any other thing you might do for weight loss except for gastric surgery which is more permanent but even then can still fail."
The medical director of the New Zealand College of General Practitioners
says more New Zealanders will be able to afford them as more versions of Ozempic and cheaper generics come on the market
He says it is likely that within 10 to 20 years half of New Zealanders will be taking the drugs
"We're going to see a real shift in their use and outcomes for patients over the next decade or so
and if we can improve the safety and the efficacy
that people will be on them if they need them and if their weight is high," Bradford tells The Detail
He notes however there is a significant proportion of people who can't take the meds because of side effects
diarrhoea; gastroparesis and pancreatic cancer in rare cases
But the drugs are also credited with preventing obesity-related cancers and heart disease
Bezzant says the implications of the weight loss drugs boom go beyond the pharmaceutical industry
Already big food companies are responding as the appetites of millions of people shrink and US takeaway chains are also adjusting their offerings
"I'm not sure if that's for better or worse," says Bezzant
"They're developing products that have maximum amounts of protein and fibre in them to keep their nutrition up while portion size has to be small because your appetite is small."
Check out how to listen to and follow The Detail here
You can also stay up-to-date by liking us on Facebook or following us on Twitter
See terms of use
for easy access to all your favourite programmes